MOSCOW (Sputnik) – The vaccination against Ebola created by Russia’s Vektor scientific center has passed the first phase of clinical tests on 60 volunteers and has shown its effectiveness, the head of Russia’s consumer watchdog said Wednesday.
“We literally turned over all the documents the day before yesterday to the Russian Health Ministry to register the first stage of clinical research…They passed successfully. The vaccine proved to be highly effective with a 100-percent [effectiveness] after two inoculations,” Rospotrebnadzor head Anna Popova said.
In March, Russia claimed it obtained the legal basis to test a recently-developed Ebola virus vaccine. According to reports, 2,000 Guinea citizens are to be vaccinated during the test.
